Analyst Report: WMT
1. EXECUTIVE SUMMARY
On August 20, 2026, shares of Walmart Inc. (NASDAQ: WMT) plummeted -9.15% to close at $103.84, posting its sharpest single-day loss in over three months on massive trading volume of 83.1 million shares. Although Walmart reported top- and bottom-line beats for fiscal Q2 2027 (revenue of $187.9B vs. $186.3B consensus; adjusted EPS of $0.81 vs. $0.73-$0.74 consensus) and raised full-year sales guidance, investors aggressively sold off the stock. The plunge was driven by a significant deceleration in U.S. same-store sales growth (2.6% vs. 3.5%-3.8% expected), disappointing Q3 FY2027 EPS guidance of $0.62–$0.64 (vs. $0.68 Wall Street consensus), margin dilution from second-half price investments, and underlying net benefits from $2.9 billion in one-time tariff refunds that inflated Q2 earnings quality. While core structural growth drivers like e-commerce (+23%) and advertising (+38%) remain robust, the market reaction reflects resetting valuations after the stock reached elevated multiples amid growing evidence of consumer spending fatigue.
2. THE CATALYST (CRITICAL)
The catalyst for the drop was the pre-market release of Walmart’s Q2 FY2027 Financial Results and forward guidance on the morning of August 20, 2026.
Headline Beats vs. Underlying Disappointments
| Metric | Q2 FY2027 Reported | Wall Street Consensus | Result |
|---|---|---|---|
| Total Revenue | $187.90 Billion | $186.30 - $186.75 Billion | BEAT (+5.9% YoY) |
| Adjusted EPS | $0.81 | $0.73 - $0.74 | BEAT (+19% YoY cc) |
| U.S. Comp Sales (ex-fuel) | +2.6% | +3.5% - +3.8% | MISS (down from +4.6% YoY) |
| Q3 FY2027 EPS Guidance | $0.62 - $0.64 | $0.68 | MISS (flat YoY growth) |
| Q3 Net Sales Growth Outlook | +3.0% to +3.75% | +4.0%+ | MISS |
Key Negative Drivers Identified in the Report & Conference Call
- Deteriorating U.S. Same-Store Sales & Traffic: Walmart U.S. comp sales slowed to 2.6%, representing its slowest quarterly same-store sales growth since the pandemic. Customer transaction growth halved sequentially to 1.5% (down from 3.0% in Q1), while average ticket growth remained tepid at 1.1%.
- Weak Q3 FY2027 Outlook: Management guided Q3 adjusted EPS to $0.62–$0.64, significantly below the $0.68 Street estimate. CFO John David Rainey noted that the calendar shift of Flipkart’s flagship Big Billion Days sale from Q3 into Q4 creates a 100+ bps headwind to Q3 international sales growth.
- Tariff Refund Accounting & Price reinvestments: Q2 gross margin (+96 bps) and operating income (+28.8% reported) were boosted by approximately $2.9 billion in one-time tariff refunds. Management explicitly noted that remaining tariff refunds would be passed through into price cuts to support struggling consumers in H2, pressuring second-half operating margins.
- Regulatory Pharmacy Headwinds: Maximum fair price regulations under the Inflation Reduction Act generated a 125 bps headwind to overall U.S. comp sales due to deflationary pharmacy pricing.
- Transportation Cost Inflation: Management flagged an estimated $2.0 billion in extra fuel and freight costs for the full year.
Sources: Walmart Inc. SEC Form 8-K Press Release (Aug 20, 2026); Business Wire (Aug 20, 2026); Zacks Equity Research (Aug 20, 2026); Investing.com (Aug 20, 2026).
3. COMPANY PROFILE
- Official Company Name: Walmart Inc.
- Core Operations: Walmart Inc. is an American multinational retail giant operating hypermarkets, discount department stores, grocery stores, and e-commerce platforms across 19 countries. It operates through three main segments: Walmart U.S. (~68% of sales), Walmart International (~19%), and Sam's Club (~13%). Groceries account for over 60% of Walmart U.S. revenues.
- Market Capitalization: ~$822.8 Billion (post-drop as of August 20, 2026).
- Sector / Industry: Consumer Staples / Broadline Retail.
- Key Competitors: Target Corporation (TGT), Costco Wholesale Corporation (COST), Amazon.com Inc. (AMZN), Kroger Co. (KR).
- 52-Week Range: $95.42 – $135.16.
- YTD Performance Context: Down ~7.0% year-to-date following the August 20 pullback.
4. DEEP DIVE ANALYSIS
Fundamentals: Justified Pullback or Overreaction?
The -9.15% drop is a combination of an overstretched valuation reset and legitimate operational headwinds. Heading into the earnings print, Walmart was trading near 36x–40x trailing earnings—well above its historical 10-year average—leaving no margin for error.
While the headline $0.81 EPS figure appeared strong, market participants correctly parsed that earnings quality was aided by $2.9 billion in tariff refunds. Without this windfall, underlying operating profits were closer to the middle of prior guidance. Furthermore, spending H2 cash on aggressive price cuts to shield lower-income shoppers implies lower near-term profitability.
Industry & Peer Context
- Target (TGT): Slipped only -0.47% on the day after reporting a stronger 3.8% comp sales growth, demonstrating that Walmart lost market share momentum to Target in discretionary/general merchandise during the quarter.
- Costco (COST): Fell -2.45%, pulled down by broad consumer defensive sector softness.
- Macro Environment: High energy/fuel prices and cumulative inflation are taking a visible toll on lower-income households, forcing trade-offs toward essential groceries and away from higher-margin general merchandise.
Strategic High-Growth Segments (The Long-Term Bull Thesis)
Despite the retail slowdown, Walmart’s transformation into a high-margin platform business remains intact:
- Global E-Commerce: +23% YoY, driven by marketplace scaling and store-fulfilled delivery.
- Global Advertising (Walmart Connect): +38% YoY growth.
- Membership Fee Income: +17% YoY growth globally.
Bull Case vs. Bear Case
| Bull Case | Bear Case |
|---|---|
| Market leadership in grocery provides structural defensive moat. | Slowing U.S. traffic (+1.5%) indicates market share gains are plateauing. |
| High-margin business lines (Advertising +38%, E-commerce +23%, Membership +17%) are expanding margins long-term. | FY27 Q3 guidance miss ($0.62–$0.64 vs $0.68) highlights H2 margin compression. |
| Management raised FY27 full-year net sales outlook to +4%-5%. | Regulatory drug price deflation and $2B extra fuel expenses weigh on gross margins. |
| Valuation lowered to more attractive entry multiples for institutional money. | Trading at >35x P/E during a consumer spending slowdown leaves limited near-term expansion. |
5. TECHNICAL SNAPSHOT
Price Chart Key Levels (Aug 20, 2026 Close) ================================================== $135.16 ---------------------------------- 52-Week High $115.65 ---------------------------------- 200-Day Moving Average (Resistance) $114.62 ---------------------------------- 50-Day Moving Average (Resistance) $103.84 ================================== CLOSE (-9.15%) $100.00 ---------------------------------- Psychological Support $95.42 ---------------------------------- 52-Week Low
- Price Action: Closed at $103.84 after touching an intraday low of $103.04. Slice-through of both 50-DMA ($114.62) and 200-DMA ($115.65) in a single session confirms strong institutional distribution.
- Volume: 83.1 million shares exchanged vs. 24.9 million 3-month average (~234% volume expansion).
- Relative Strength Index (RSI-14): Dropped precipitously from ~43 to 29.38, pushing WMT into technically oversold territory.
- Key Support Levels: $100.00 (psychological round number), followed by $95.42 (52-week low).
- Key Resistance Levels: $108.00–$110.00 gap window, followed by $114.60–$115.65 (converging 50/200 DMAs).
6. RISK FACTORS
- Lower-Income Consumer Stress: Continued high fuel prices and food inflation could force further trade-offs, suppressing higher-margin discretionary purchases.
- Promotional Environment & Margin Compression: Passing tariff refunds directly to price investments in H2 could trigger a retail price war with Target and regional grocers, squeezing operating margins.
- Execution on Flipkart's BBD Sale: Shifting the major international sale event into Q4 leaves zero room for logistics or supply-chain bottlenecks during the holiday season.
- Pharmaceutical Deflation: Persistent Inflation Reduction Act drug-pricing mandates could remain a multi-quarter drag on health & wellness revenue comps.
7. ACTIONABLE OUTLOOK
Short-Term (1–2 Weeks)
- Expectation: Range-bound consolidation between $100.00 and $108.00.
- Driver: With the 14-day RSI oversold at 29.38, a technical relief bounce toward $108.00 is likely. However, heavy overhead supply around $114–$115 will cap aggressive upside rallies until Q3 guidance can be reassessed.
Medium-Term (1–3 Months)
- Expectation: Range-bound to mild accumulation ($102.00 – $115.00).
- Driver: Investors will monitor back-to-school spending metrics and early holiday shopping indicators. Confirmation of market share gains in grocery and continued scaling of ad revenue will be required for the stock to reclaim its 200-day moving average ($115.65).
Long-Term Thesis
- Status: UNCHANGED (BUY ON DIPS).
- Reasoning: The fundamental long-term thesis for Walmart as a technology-enabled, multi-stream retail leader remains intact. The 9.15% drop successfully derisked a stretched multi-year valuation multiple. Accelerated growth in digital advertising (+38%), e-commerce (+23%), and high-margin membership revenue (+17%) guarantees structural margin expansion over a 3- to 5-year horizon, making this sell-off an attractive accumulation window for institutional long-term portfolios.